Everolimus
NDC 0054-0480, Everolimus, tablet, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0054-0480
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207486
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0480 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EVEROLIMUS2.5 mg/1
Pharmacologic classes
Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Decreased Immunologic Activity [PE]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]; mTOR Inhibitor Immunosuppressant [EPC]; mTOR Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0480-13 | 00054048013 | 30 TABLET in 1 BOTTLE (0054-0480-13) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5aaf2fb7-93f6-40d6-941a-9583a3794ce7
Use it
Look up 0054-0480 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0480 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0480. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.